sorafenib has been researched along with 1-monooleoyl-rac-glycerol in 1 studies
Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (1-monooleoyl-rac-glycerol) | Trials (1-monooleoyl-rac-glycerol) | Recent Studies (post-2010) (1-monooleoyl-rac-glycerol) |
---|---|---|---|---|---|
6,520 | 730 | 5,251 | 610 | 0 | 278 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Griffin, BT; Holm, R; Koehl, NJ; Kuentz, M | 1 |
1 other study(ies) available for sorafenib and 1-monooleoyl-rac-glycerol
Article | Year |
---|---|
Chase Dosing of Lipid Formulations to Enhance Oral Bioavailability of Nilotinib in Rats.
Topics: Animals; Biological Availability; Chemistry, Pharmaceutical; Diglycerides; Dose-Response Relationship, Drug; Excipients; Hydrophobic and Hydrophilic Interactions; Lipids; Liposomes; Male; Monoglycerides; Oleic Acids; Olive Oil; Pyrimidines; Rats; Rats, Sprague-Dawley; Solubility; Sorafenib; Suspensions; Water | 2020 |